Biotech buyout? Teva's $40 billion bid
watch now

In this video

Share
Closing Bell

Biotech buyout? Teva's $40 billion bid

Teva is offering $40 billion to buy Mylan. Barbara Ryan, Clemont Partners, and CNBC's Meg Tirrell, provide perspective on the potential consolidation.
03:19
Tue, Apr 21 20153:30 PM EDT

Kelly Evans